Lisa Potthast, PA-C

Lisa Potthast is a certified Physician Assistant in the Department of Radiation Oncology at Moffitt Cancer Center.  Ms. Potthast received her undergraduate training at Florida Southern College in Lakeland, FL and graduate degree at the University of Florida, Gainesville. She has been a Physician Assistant since 2003 and has worked at Moffitt Cancer Center since January 2005. During her tenure at Moffitt, she has cared for patients in the Neuro-Oncology Program, Genitourinary Oncology Program and most recently in the Radiation Oncology Program with a focus in Cutaneous Oncology. Ms. Potthast serves on the Medical Ethics committee and participates as guest lecturer once monthly for the “Meet the Expert” series educating patients and families about Radiation Therapy and side effect management.  She actively participates in mentoring those interested in the PA profession as well as current Advanced Practice Professional students.  She is board certified by the National Commission on the Certification of Physician Assistants (NCCPA) and licensed by the State of Florida Board of Medicine.

Education & Training

Board Certification:

• Medicine -

Medical School:

• University of South Florida - MS Physician Assistant studies

• Forsyth PA, Krishna N, Lawn S, Valadez JG, Qu X, Fenstermacher DA, Fournier M, Potthast L, Chinnaiyan P, Gibney GT, Zeinieh M, Barker PA, Carter BD, Cooper MK, Kenchappa RS. p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells. J Biol Chem. 2014 Mar.289(12):8067-8085. Pubmedid: 24519935. Pmcid: PMC3961639.
• Pan E, Yu D, Yue B, Potthast L, Chowdhary S, Smith P, Chamberlain M. A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma. J Neurooncol. 2012 Oct.110(1):111-118. Pubmedid: 22832897. Pmcid: PMC5735835.
• Chinnaiyan P, Chowdhary S, Potthast L, Prabhu A, Tsai YY, Sarcar B, Kahali S, Brem S, Yu HM, Rojiani A, Murtagh R, Pan E. Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma. Neurooncol. 2012 Jan.14(1):93-100. Pubmedid: 22028388. Pmcid: PMC3246000.
• Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol. 2007 Mar.82(1):81-83. Pubmedid: 16944309.
• Chowdhary S, Chalmers L, Chamberlain M. Non-HIV-related progressive multifocal leukoencephalopathy (PML): a tertiary cancer center experience. J Neuroimaging. 2007 Jan.17(1):69-73. Pubmedid: 17238872.
• Chamberlain M, Chalmers L. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. J Neurooncol. 2007 Apr.82(2):207-209. Pubmedid: 17019532.